Abstract:In vitro and in vivo testing showed a safe and effective function of the ReinHeart-TAH system. This has the potential to become an alternative to transplantation. However, before a first-in-man implant, chronic animal trials still have to be completed.
“…The system consists of a passive filling pump driven by two artificial ventricles, an implantable control unit, and a compliance chamber [22] (Fig. 3d).…”
Section: Key Pointsmentioning
confidence: 99%
“…The preliminary animal data suggests high durability with significantly reduced areas of blood pooling, whereby within three cycles over 99% of the blood filling the ventricles was washed out, thus reducing thrombosis risk to the patient. The passively filled pump is highly preload sensitive, allowing the system to adapt to the patient's CO needs, generating up to 60 ml of stroke volume per cycle [22].…”
Section: Key Pointsmentioning
confidence: 99%
“…All components are internalized (pump, controller with batteries, internal TET coil, and compliance chamber); the pump has the potential to provide 5 years or more of support. The required mean power is less than 20 W and is transmitted transcutaneously [22]. The purpose of the implantable controller is to power and control the pump unit and compliance chamber, in addition to providing a battery back up in case of a TET system failure, which powers all implantable components.…”
Section: Completely Internalizedmentioning
confidence: 99%
“…The purpose of the implantable controller is to power and control the pump unit and compliance chamber, in addition to providing a battery back up in case of a TET system failure, which powers all implantable components. With optimal coupling between the coils, power losses are low and local heating is minimized; the TET system can support the device up to a distance and misalignment of 30 mm [22]. Free range resonant electrical delivery wireless power systems (FREE-D WiTricity's) are a proprietary wireless resonant energy transfer technology that utilizes magnetically coupled resonators to transfer power over a distance of 2-3 m. The transfer of energy is less restricted by misalignment and interferences from surrounding objects [29].…”
The role for MCS in advanced heart replacement therapy is steadily increasing. With the advent of newer generation devices on the horizon, the potential exists for MCS to surpass heart transplantation as the primary therapy for advanced heart failure.
“…The system consists of a passive filling pump driven by two artificial ventricles, an implantable control unit, and a compliance chamber [22] (Fig. 3d).…”
Section: Key Pointsmentioning
confidence: 99%
“…The preliminary animal data suggests high durability with significantly reduced areas of blood pooling, whereby within three cycles over 99% of the blood filling the ventricles was washed out, thus reducing thrombosis risk to the patient. The passively filled pump is highly preload sensitive, allowing the system to adapt to the patient's CO needs, generating up to 60 ml of stroke volume per cycle [22].…”
Section: Key Pointsmentioning
confidence: 99%
“…All components are internalized (pump, controller with batteries, internal TET coil, and compliance chamber); the pump has the potential to provide 5 years or more of support. The required mean power is less than 20 W and is transmitted transcutaneously [22]. The purpose of the implantable controller is to power and control the pump unit and compliance chamber, in addition to providing a battery back up in case of a TET system failure, which powers all implantable components.…”
Section: Completely Internalizedmentioning
confidence: 99%
“…The purpose of the implantable controller is to power and control the pump unit and compliance chamber, in addition to providing a battery back up in case of a TET system failure, which powers all implantable components. With optimal coupling between the coils, power losses are low and local heating is minimized; the TET system can support the device up to a distance and misalignment of 30 mm [22]. Free range resonant electrical delivery wireless power systems (FREE-D WiTricity's) are a proprietary wireless resonant energy transfer technology that utilizes magnetically coupled resonators to transfer power over a distance of 2-3 m. The transfer of energy is less restricted by misalignment and interferences from surrounding objects [29].…”
The role for MCS in advanced heart replacement therapy is steadily increasing. With the advent of newer generation devices on the horizon, the potential exists for MCS to surpass heart transplantation as the primary therapy for advanced heart failure.
“…A different, linear, electromagnetic direct-drive concept is realized in the ReinHeart TAH, which is being developed at the Institute for Applied Medical Engineering in Aachen, Germany [8]. The ReinHeart is a fully implantable artificial heart system designed with minimal wear components to ensure high durability.…”
Besides the use in a TAH, the presented PSS's can be employed in a wide use of miniaturized applications. The introduced testing method allows the validation for general miniaturized applications, e.g., linear motor drives.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.